John H. Barton, JD
Professor of Law, Emeritus and FSI Senior Fellow, by courtesy; CHP/PCOR Associate (former)
Stanford Law School
Crown Quad 237
Stanford, CA 94305-8610
Research Interests
technology law; the transfer of technology to developing nations; intellectual property, particularly as related to biotechnology
John Barton's Curriculum Vitae (19.4KB, modified March 2006)
John Barton is a professor emeritus at the Stanford Law School, an FSI senior fellow by courtesy, and a CHP/PCOR associate. He has taught at Stanford since 1969, with a variety of courses focused on international law and technology law. His research and publications focus on international scientific research and cooperation, the relationship between intellectual property and antitrust, and the transfer of technology -- particularly vaccine production technology -- to developing countries.
Barton has recently published an article in the Journal of the American Medical Association on the pharmaceutical development process, and is co-author of the product development priorities chapter in the forthcoming book Disease Control Priorities in Developing Countries. He has participated extensively in discussions regarding drug access for developing nations. He is also interested in the marketing structure of the pharmaceutical industry and the impact of vaccine regulation on the structure of the international vaccine industry.
For the 2004-05 academic year, Barton was a visiting scholar at the National Institutes of Health's Department of Clinical Bioethics. He chaired the U.K. Commission on Intellectual Property Rights in 2001-2002. He was a member of National Research Council's committees on intellectual property and on genetic resources; of the Nuffield Council on Bioethics committee on gene patenting; and of two working groups of the Sachs Commission on Macroeconomics and Health. He received his undergraduate degree from Marquette University in 1958, and his JD from Stanford in 1968.
Stanford Departments
Law
Publications
The patents-based pharmaceutical development process: rationale, problems, and potential reforms
John H. Barton, EJ Emanuel
Journal of the American Medical Association vol. 294, 16 (2005)
TRIPS and the Global Pharmaceutical Market
John H. Barton
Health Affairs vol. 23, 3 (2004)
Patents, genomics, research, and diagnostics
John H. Barton
Academic Medicine vol. 77 (2002)
Model Protocol to Assess the Risks of Agricultural Introductions: A Risk-Based Approach to Rationalizing Field Trial Regulations, A
Donald Kennedy, John H. Barton, John Crandon, Henry Miller
Nature Biotechnology vol. 15 (1997)
Events & Presentations
Developing World Drug Access: A New Approach
July 18, 2007 CHP/PCOR Research in Progress Seminar
John H. Barton
Political Theory Issues For International Economic Equity
May 3, 2006 CDDRL Research Seminar
John H. Barton
A Political Theory of International Organization: the Human Rights and International Conflict Issues
March 9, 2006 Social Science Seminar
John H. Barton
Vaccine Technology in Developing Nations
February 1, 2006 CHP/PCOR Research in Progress Seminar
John H. Barton
presentation available- The EU, the US and the WTO
February 28, 2003 - March 1, 2003 FSI Stanford, The Europe Center Workshop
Andrew Stoler, Richard Steinberg, Judy Goldstein, John H. Barton, Bart Kerremans, Anthony Gooch, Stephen Woolcock, Bruce Stokes, Mac Destler, Jeff Schott, Richard Morningstar, Timothy E. Josling, Geza Feketekuty, Dale Hathaway, John Nash
conference agenda available



About CISAC
Mailing List
@StanfordCISAC
Facebook